JERUSALEM, April 6 (Xinhua) -- Israeli medical tech company AID Genomics will collaborate with Chinese biotech giant BGI Genomics to set up a coronavirus testing lab in the Palestinian city of Gaza, the Israeli company said Monday.
AID Genomics said the emergency testing laboratory, approved by both Israeli and Palestinian authorities, will perform up to 3,000 COVID-19 tests daily for Gaza residents.
AID Genomics, founded in 2014 and based in the central city of Rehovot, specializes in the diagnosis and therapy of cancer. The company develops and performs genomic and genetic testing for accurate and personalized cancer care.
AID has already supplied Israel with hundreds of thousands of test kits, developed by BGI.
BGI Genomics, founded in 1999, has been a major supplier of COVID-19 tests. The company, based in Shenzhen, China, is a leading provider of genomic sequencing and proteomic services.
BGI is actively participating in the fields of cancer research, bio-sustainability and personalized medicine through a global network of collaborators.
Latest comments